UroGen Pharma Ltd | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pontifax Management III G.P. (2011) Ltd.(4.4%),Pontifax Management Fund III L.P.(4.4%), etc.
UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.6%),Point72 Capital Advisors, Inc.(3.6%), etc.
UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(7.1%),Peter Kolchinsky(7.1%), etc.
UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Great Point Partners, LLC(1.80%),Dr. Jeffrey R. Jay, M.D.(1.80%), etc.
UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Menora Mivtachim Holdings Ltd.(5.47%),Menora Mivtachim Pensions and Gemel Ltd.(4.79%)
UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)
UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cowen Financial Products LLC(4.3%),Cowen and Company, LLC(0%)
UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Management, L.P.(8.87%),Robert Atchinson(8.87%), etc.
UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.9%)
UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-Morgan Stanley(5.2%)
UroGen Pharma Ltd | 10-Q: Q3 2024 Earnings Report
UroGen Pharma Ltd | 8-K: UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025
UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.9%)
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Degnan Chris
UroGen Pharma Ltd | 3: Initial statement of beneficial ownership of securities-Officer Degnan Chris
UroGen Pharma Ltd | 8-K: Current report
UroGen Pharma Ltd | 8-K: Current report
UroGen Pharma Ltd | 8-K: Current report
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Schoenberg Mark
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Smith Jason Drew
No Data